Toward responsible artificial intelligence in health: regulatory structures and power dynamics of the big tech industry in the United States.

Artificial intelligence (AI) offers potential strategies to address existing challenges facing health systems in the United States (U.S.). However, the development of the AI market for health care over the past decade also poses risks to public value in the short- and long-term. In this commentary, we describe the nature of large technology companies’ interface with health care in the U.S., outlining their roles in the context of their leadership in the platform economy. First, we describe the risks associated with the potential dominance of Big Tech companies in healthcare and outline the short-term context for regulating AI as it relates to Big Tech’s role in healthcare. We then explore the possibilities of regulatory approaches that might encourage the anticipation of risks and enforcement of responsible technology practices while retaining the goal of enhancing public value as a primary aim of healthcare policy. [ABSTRACT FROM AUTHOR]